Literature DB >> 22203620

Sexual assault nurse examiners' perceptions of their relationship with doctors, rape victim advocates, police, and prosecutors.

Shana L Maier1.   

Abstract

In response to the negative and inefficient treatment of rape victims by emergency room personnel, the first Sexual Assault Nurse Examiner (SANE) programs began in the late 1970s. While SANEs, doctors, rape victim advocates, police officers and prosecutors work together to ensure the most comprehensive and sensitive care of rape victims, they all have very different roles and objectives. This research explores SANEs' perceptions of their relationships with other professionals who treat or interact with rape victims. Data from interviews with 39 Sexual Assault Nurse Examiners from four East Coast states indicate positive relationships are marked by open communication, respect shown towards SANEs as well as rape victims, and a sense of appreciation among SANEs. On the contrary, negative relationships result when SANEs believe police treat victims poorly, when advocates overstep boundaries and question SANEs about evidence collection or the exam, and when prosecutors fail to properly prepare them to testify during a trial.

Entities:  

Mesh:

Year:  2011        PMID: 22203620     DOI: 10.1177/0886260511425242

Source DB:  PubMed          Journal:  J Interpers Violence        ISSN: 0886-2605


  2 in total

1.  "Catching flies with honey": the management of conflict in Sexual Assault Response Teams.

Authors:  Carrie A Moylan; Taryn Lindhorst
Journal:  J Interpers Violence       Date:  2014-09-22

2.  The identification and treatment of mental health and substance misuse problems in sexual assault services: A systematic review.

Authors:  Theodora Stefanidou; Elizabeth Hughes; Katherine Kester; Amanda Edmondson; Rabiya Majeed-Ariss; Christine Smith; Steven Ariss; Charlie Brooker; Gail Gilchrist; Sarah Kendal; Mike Lucock; Fay Maxted; Concetta Perot; Rebekah Shallcross; Kylee Trevillion; Brynmor Lloyd-Evans
Journal:  PLoS One       Date:  2020-04-10       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.